AMN Healthcare Services, Inc. (AMN)
| Market Cap | 1.14B +56.0% |
| Revenue (ttm) | 3.42B +19.9% |
| Net Income | -32.44M |
| EPS | -0.84 |
| Shares Out | 38.79M |
| PE Ratio | n/a |
| Forward PE | 34.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,604,480 |
| Open | 30.11 |
| Previous Close | 30.27 |
| Day's Range | 28.11 - 30.53 |
| 52-Week Range | 14.87 - 31.65 |
| Beta | 0.30 |
| Analysts | Buy |
| Price Target | 23.25 (-21.11%) |
| Earnings Date | May 7, 2026 |
About AMN
AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, ... [Read more]
Financial Performance
In 2025, AMN Healthcare Services's revenue was $2.73 billion, a decrease of -8.49% compared to the previous year's $2.98 billion. Losses were -$95.70 million, -34.89% less than in 2024.
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for AMN stock is "Buy." The 12-month stock price target is $23.25, which is a decrease of -21.11% from the latest price.
News
AMN Healthcare price target raised to $26 from $25 at BMO Capital
BMO Capital raised the firm’s price target on AMN Healthcare (AMN) to $26 from $25 and keeps an Outperform rating on the shares. The company’s Q1 upside was boosted by…
AMN Healthcare price target raised to $26 from $23 at Baird
Baird raised the firm’s price target on AMN Healthcare (AMN) to $26 from $23 and keeps a Neutral rating on the shares. The firm updated its model following strong Q1…
AMN Healthcare price target raised to $26 from $24 at Truist
Truist analyst Tobey Sommer raised the firm’s price target on AMN Healthcare (AMN) to $26 from $24 and keeps a Buy rating on the shares after its Q1 earnings beat,…
AMN Healthcare Services Earnings Call Transcript: Q1 2026
Q1 2026 saw record revenue and margin outperformance, driven by major labor disruption events and strong execution in core staffing segments. Guidance anticipates normalization in Q2, with continued growth in international and allied staffing, and a stable leverage profile.
AMN Healthcare Announces First Quarter 2026 Results
Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million ; GAAP income of $1.59 /share and adjusted EPS of $2.10 DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. ...
AMN Healthcare Services Transcript: AGM 2026
The meeting covered director elections, executive compensation, auditor ratification, and equity plan amendment, with all board proposals passing. A shareholder proposal for an independent board chairman was discussed but did not pass. Technology initiatives and travel nurse segment trends were also addressed.
AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2026 financial results and second quarter 2026 outloo...
AMN Healthcare Survey Reveals Sharp Divide Between Leaders' Organizational Confidence and Industry Outlook for 2026
Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag Survey of 700+ executives shows AI leadership roles surging as succession planning and c...
AMN Healthcare price target raised to $24 from $22 at Citizens
Citizens analyst Constantine Davides raised the firm’s price target on AMN Healthcare (AMN) to $24 from $22 and keeps an Outperform rating on the shares. AMN Healthcare may deserve increased…
AMN Healthcare price target raised to $19.50 from $19 at UBS
UBS raised the firm’s price target on AMN Healthcare (AMN) to $19.50 from $19 and keeps a Neutral rating on the shares.
AMN Healthcare price target raised to $23 from $21 at Baird
Baird analyst Mark Marcon raised the firm’s price target on AMN Healthcare (AMN) to $23 from $21 and keeps a Neutral rating on the shares. The firm updated its model…
UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Quarterly revenue of $748 million ; GAAP loss of ($0.20) /share and adjusted EPS of $0.22
AMN Healthcare Services Earnings Call Transcript: Q4 2025
Q4 2025 saw revenue growth driven by labor disruption events, with full year revenue at $2.73B and significant debt reduction. Guidance for Q1 2026 includes $600M in labor disruption revenue, while underlying business trends remain stable and long-term growth targets are 4%-6% annually.
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Quarterly revenue of $748 million ; GAAP loss of ($0.20) /share and adjusted EPS of $0.22
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
DALLAS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2025 financial results and first quarte...
AMN Healthcare price target raised to $25 from $22 at BMO Capital
BMO Capital raised the firm’s price target on AMN Healthcare (AMN) to $25 from $22 and keeps an Outperform rating on the shares. The firm is adjusting its estimates after…
AMN Healthcare price target lowered to $22 from $24 at Citizens
Citizens lowered the firm’s price target on AMN Healthcare (AMN) to $22 from $24 and keeps an Outperform rating on the shares. The firm’s December Staffing Trends report updates provider…
AMN Healthcare price target raised to $20.50 from $18 at UBS
UBS raised the firm’s price target on AMN Healthcare (AMN) to $20.50 from $18 and keeps a Neutral rating on the shares.
AMN Healthcare price target raised to $24 from $22 at Citizens JMP
Citizens JMP raised the firm’s price target on AMN Healthcare (AMN) to $24 from $22 and keeps an Outperform rating on the shares. Management noted that travel nurse demand has…
AMN Healthcare Services Earnings Call Transcript: Q3 2025
Q3 revenue and margins exceeded guidance despite year-over-year declines, with all segments beating consensus. Labor disruption and mix shifts pressured margins, but demand and bill rates are stabilizing, and 2026 is expected to bring margin improvement and growth in high-margin services.
AMN Healthcare Announces Third Quarter 2025 Results
Quarterly revenue of $634 million and adjusted EBITDA of $58 million ; GAAP income of $0.76 /share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (N...
AMN Healthcare price target raised to $24 from $20 at Truist
Truist raised the firm’s price target on AMN Healthcare (AMN) to $24 from $20 and keeps a Buy rating on the shares as part of a broader research note on…
AMN Healthcare to Hold Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025
DALLAS, Oct. 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2025 financial results and fourth quarter 2025 outlook...
AMN Healthcare Services Transcript: Jefferies 2025 Healthcare Services Conference
The business is seeing stabilization in demand and patient volumes, with winter orders tracking as expected and a strong focus on technology-driven solutions. Recent debt refinancing has improved financial flexibility, while easing visa retrogression is set to boost international growth in 2025.
AMN Healthcare Announces Pricing of Senior Notes Offering
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private of...